Oligogalacturonic acid inhibit bone resorption and collagen degradation through its interaction with type I collagen

Biochemical Pharmacology

Volumn 78, Issue 12, 2009, Pages 1448-1455

  Lion, Jean Marc ^a   Mentaverri, Romuald ^a   Rossard, Stéphanie ^a   Jullian, Nathalie ^a   Courtois, Bernard ^a   Courtois, Josiane ^a   Brazier, Michel ^a   Mazière, Jean Claude ^a   Kamel, Said ^a  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Bone resorption; Collagen breakdown; Lysosomal cysteine protease; Matrix metalloproteinase; Osteoclast; Type I collagen

Indexed keywords

ALBUMIN; CARBOHYDRATE DERIVATIVE; CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; COLLAGEN TYPE 1; GELATINASE B; OLIGOGALACTURONIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; MALE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RABBIT;

ANIMALS; APOPTOSIS; BIOLOGICAL ASSAY; BONE RESORPTION; CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; COLLAGEN; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; OLIGOSACCHARIDES; OSTEOCLASTS; RABBITS;

EID: 70349984551     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.07.014     Document Type: Article

References (24)

1. Suda T., Takahashi N., and Martin T.J. Endocr Rev 13 1 (1992) 66-80
2. Roodman G.D. Endocr Rev 17 4 (1996) 308-332
3. Miyamoto T., and Suda T. Keio J Med 52 1 (2003) 1-7
4. Vaananen K. Adv Drug Deliv Rev 57 7 (2005) 959-971
5. Inaoka T., Bilbe G., Ishibashi O., Tezuka K., Kumegawa M., and Kokubo T. Biochem Biophys Res Commun 206 1 (1995) 89-96
6. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S., et al. J Biol Chem 273 48 (1998) 32347-32352
7. Everts V., Korper W., Hoeben K.A., Jansen I.D., Bromme D., Cleutjens K.B., et al. J Bone Miner Res 21 9 (2006) 1399-1408
8. Manolagas S.C. Endocr Rev 21 2 (2000) 115-137
9. Kameda T., Mano H., Yuasa T., Mori Y., Miyazawa K., Shiokawa M., et al. J Exp Med 186 4 (1997) 489-495
10. Mayahara M., and Sasaki T. Anat Rec A Discov Mol Cell Evol Biol 274 1 (2003) 817-826
11. Reginster Y., and Reginster J.Y. Biodrugs 10 4 (1998) 295-300
12. Michael H., Harkonen P.L., Kangas L., Vaananen H.K., and Hentunen T.A. Br J Pharmacol 151 3 (2007) 384-395
13. Nzeusseu A., Dienst D., Haufroid V., Depresseux G., Devogelaer J.P., and Manicourt D.H. Bone 38 3 (2006) 394-399
14. Takahara S., Morohashi T., Sano T., Ohta A., Yamada S., and Sasa R. J Nutr 130 7 (2000) 1792-1795
15. Zafar T.A., Weaver C.M., Zhao Y., Martin B.R., and Wastney M.E. J Nutr 134 2 (2004) 399-402
16. Nangia-Makker P., Hogan V., Honjo Y., Baccarini S., Tait L., Bresalier R., et al. J Natl Cancer Inst 94 24 (2002) 1854-1862
17. Platt D., and Raz A. J Natl Cancer Inst 84 6 (1992) 438-442
18. Tezuka K., Sato T., Kamioka H., Nijweide P.J., Tanaka K., Matsuo T., et al. Biochem Biophys Res Commun 186 2 (1992) 911-917
19. Lorget F., Kamel S., Mentaverri R., Wattel A., Naassila M., Maamer M., et al. Biochem Biophys Res Commun 268 3 (2000) 899-903
20. Votta B.J., Levy M.A., Badger A., Bradbeer J., Dodds R.A., James I.E., et al. J Bone Miner Res 12 9 (1997) 1396-1406
21. Parfitt A.M., Mundy G.R., Roodman G.D., Hughes D.E., and Boyce B.F. J Bone Miner Res 11 2 (1996) 150-159
22. Lecaille F., Bromme D., and Lalmanach G. Biochimie 90 2 (2008) 208-226
23. Grabowskal U., Chambers T.J., and Shiroo M. Curr Opin Drug Discov Dev 8 5 (2005) 619-630
24. Selent J., Kaleta J., Li Z., Lalmanach G., and Bromme D. J Biol Chem 282 22 (2007) 16492-16501